Dengue pre-vaccination screening and positive predictive values

被引:18
作者
Rodriguez-Barraquer, Isabel [1 ]
Salje, Henrik [2 ,3 ,4 ,5 ,6 ]
Cummings, Derek A. T. [6 ,7 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA
[2] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France
[3] CNRS, URA3012, Paris, France
[4] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] Univ Florida, Dept Biol, Gainesville, FL USA
[7] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA
关键词
D O I
10.1016/S1473-3099(18)30799-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:132 / 134
页数:5
相关论文
共 6 条
[1]  
[Anonymous], REV SAGE REC US DENG
[2]  
Espana G, 2018, BIORXIV, DOI [10.1101/367060, DOI 10.1101/367060]
[3]  
Sanofi, 2018, FDA GRANTS PRIOR REV
[4]  
Sanofi, 2018, SAN REC POS CHMP OP
[5]  
Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI [10.1056/NEJMoa1800820, 10.1056/nejmoa1800820]
[6]   Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine [J].
Wilder-Smith, Annelies ;
Hombach, Joachim ;
Ferguson, Neil ;
Selgelid, Michael ;
Brien, Kate O. ;
Vannice, Kirsten ;
Barrett, Alan ;
Ferdinand, Elizabeth ;
Flasche, Stefan ;
Guzman, Maria ;
Novaes, Hillegonde Maria ;
Ng, Lee-Ching ;
Smith, Peter G. ;
Tharmaphornpilas, Piyanit ;
Yoon, In-Kyu ;
Cravioto, Alejandro ;
Farrar, Jeremy ;
Nolan, Terry M. .
LANCET INFECTIOUS DISEASES, 2019, 19 (01) :E31-E38